FDA鈥檚 Drug Approval Team Copes With 700 Unfilled Jobs As Industry Lures Staff
The FDA鈥檚 drug-approval team is short more than 700 people and losing skilled staff members to the drug industry.
Drugs
1,201 - 1,220 of 1,300 Results
-
-
Study: 鈥楿biquitous鈥 Nature Of Painkillers Lands Kids 鈥 Even Toddlers 鈥 In The ER
New research tracks how the widespread availability of these high-powered medications is causing a high rate of hospitalizations for opioid poisoning among children.
-
Drug Prices, Not The Health Law, Top Voters鈥 Health Priorities For 2017
Majorities of Democrats, Republicans and independents support making sure high-cost drugs for chronic conditions are affordable.
By Julie Rovner -
West Virginia Grapples With High Drug Costs
Climbing drug prices are taking a toll on West Virginia's budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.
-
7 Insurers Alleged To Use Skimpy Drug Coverage To Discourage HIV Patients
The plans sought to discourage costly HIV patients by not including their drug needs in formularies or requiring high cost sharing, a Harvard Law School group says in a complaint filed with HHS.
-
Hospitals Say They鈥檙e Being Slammed By Drug Price Hikes
In a report out Tuesday, hospital groups said drug prices have skyrocketed since 2013, triggering a huge increase in what hospitals spend on pharmaceuticals.
-
Tracking Who Makes Money On A Brand-Name Drug
KHN鈥檚 Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug鈥檚 cost.
-
Many Doctors Treating Alcohol Problems Overlook Successful Drugs
Two prescription medications have been found to be successful in helping many patients with alcohol cravings. Yet they are rarely used and many patients don鈥檛 know they exist.
-
Young Boy鈥檚 Struggle To Survive Sparked Push For Drugs For Terminally Ill
Ten-year-old Josh Hardy died last month. His struggle to survive helped to spur laws to get unapproved drugs to the terminally ill.
By Liz Szabo -
The Need To Replace EpiPens Regularly Adds To Concerns About Cost
The drug鈥檚 manufacturer says it has an expiration date of 12 to 18 months but that includes distribution time, so many customers find they have to buy a new device at least once a year.
-
The Orphan Drug Machine
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder 鈥 and then used to speed up approvals for much more common drugs.
-
Poll Finds Majority Of Americans Want Restraints On Drug Prices
As the spiraling costs attract headlines, many people are looking to the government to rein in prescription drug prices, according to the Kaiser Family Foundation poll.
By Jordan Rau -
Large Danish Study Links Contraceptive Use To Risk Of Depression
The research, published in JAMA Psychiatry, finds significant increases in the use of anti-depressants and depression diagnoses for women using hormonal forms of contraceptives, such as the pill.
-
Specialty Drug Costs Soar 30% For California Pension Fund
Such medications account for more than a quarter of the state agency鈥檚 $2.1 billion in pharmacy costs.
By Chad Terhune -
When Drug Reviewers Leave The FDA, They Often Work For Pharma
Researchers examine the Food and Drug Administration鈥檚 鈥渞evolving door鈥 regarding employees who worked on cancer and hematology drugs.
-
It鈥檚 Not Just For Kids: Medicare EpiPen Spending Up 1,100 Percent
The number of prescriptions for Medicare beneficiaries is on the rise, too.
By Julie Appleby and Mary Agnes Carey -
Veterans Courted In California’s Ballot Fight Over Curbing Drug Prices
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans鈥 sympathetic and trusted image to win over voters.
-
FDA Approves First Drug To Treat Rare Form Of Muscular Dystrophy
The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease.
By Liz Szabo -
Candidates Decry High Drug Prices, But They Have Few Options For Voters
Drug prices rise for a variety of reasons but opportunities for the government to control them is limited.
By Julie Rovner -
The Ads Say 鈥楪et Your Flu Shot Today,鈥 But It May Be Wiser To Wait
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.